Pneumococcal Articles and Studies

  • CDC released new pneumococcal vaccination recommendations. Adults 65 years of age or older are now recommended to get the pneumococcal conjugate vaccine (PCV13, Prevnar-13®)  followed by the pneumococcal polysaccharide vaccine (PPSV23, Pneumovax®23) 6-12 months later. Read full article, Use of 13-Valent Pneumococcal Conjugate Vaccine and 23-Valent Pneumococcal Polysaccharide Vaccine Among Adults Aged ≥65 Years: Recommendations of the Advisory Committee on Immunization Practices (ACIP), MMWR  Sept. 19, 2014. (63)37;822-825

  • The New England Journal of Medicine (NEJM) released the following article, which indicates that vaccinating children against pneumococcal pneumonia cut hospitalizations over the past decade in almost all age groups: Griffin M, Zhu Y, et.al. U.S. Hospitalizations for Pneumonia after a Decade of Pneumococcal Vaccination New England Journal of Medicine (NEJM) (2013) 369:155-163. DOI: 10.1056/NEJMoa1209165

 

 

 

 

 Updated 9/11/15

 

 

 

 

 

 

 

 

 

 

 

 

 

 

This website is supported by an independent educational grant from Merck and an educational grant from Sanofi Pasteur U.S. 
ACOG does not allow companies to influence its programs, publications, or advocacy positions.